# \[e-drug\] Short program on Pharmacovigilance and Drug Monitoring

**URL:** <https://talk.edrugplus.org/t/e-drug-short-program-on-pharmacovigilance-and-drug-monitoring/43739>\
**Category:** e-drug\
**Created:** [June 28, 2017, 3:26am UTC](https://talk.edrugplus.org/t/e-drug-short-program-on-pharmacovigilance-and-drug-monitoring/43739 "2017-06-28T03:26:52Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![rahul\_sharma](https://avatars.discourse-cdn.com/v4/letter/r/df705f/32.png) [@rahul\_sharma](https://talk.edrugplus.org/u/rahul_sharma)\
**Post date:** [June 28, 2017, 3:26am UTC](https://talk.edrugplus.org/t/e-drug-short-program-on-pharmacovigilance-and-drug-monitoring/43739/1 "2017-06-28T03:26:52Z")

</div>

E-DRUG: Short program on Pharmacovigilance and Drug Monitoring  
----------------------------------------------------------------------------------

MDP on "Pharmacovigilance and Drug Monitoring " October 30 - November 3,  
2017\*

Pharmacovigilance is the process of monitoring and enabling an environment  
for the control of adverse drug reaction. There is a need to strengthen the  
Pharmacovigilance system and make it beneficiary to the population,  
understanding various aspects of Pharmacovigilance is essential as the  
treatments are monitored for their safety and effectiveness under real-life  
conditions post-market release. The program is going to emphasize upon  
Pharmacovigilance information into action, describe and analyze the  
risk/benefit, economics of drug use and to advise for decision making.

Major program contents

&nbsp;&nbsp;&nbsp;- Current status & issues of Post-marketing studies Adverse event (AE),  
&nbsp;&nbsp;&nbsp;reporting procedures, risk/benefit analysis for the use of medicines  
&nbsp;&nbsp;&nbsp;- Design of Post-marketing studies  
&nbsp;&nbsp;&nbsp;- Reporting Guidelines  
&nbsp;&nbsp;&nbsp;- Spontaneous Reporting  
&nbsp;&nbsp;&nbsp;- Prescription event monitoring  
&nbsp;&nbsp;&nbsp;- Drug utilization studies  
&nbsp;&nbsp;&nbsp;- Signal Detection & Analysis  
&nbsp;&nbsp;&nbsp;- Causality assessment of adverse event  
&nbsp;&nbsp;&nbsp;- Drug Coding & PV Data Management  
&nbsp;&nbsp;&nbsp;- Periodic Safety Update Report  
&nbsp;&nbsp;&nbsp;- Setting-up of PV center & Operationalization  
&nbsp;&nbsp;&nbsp;- ICH- GCP Guidelines & Global PV Regulation

The program will be organized in IIHMR University, Jaipur, India which is  
ranked No. 1 B-School in Health Sector in India (Outlook Magazine). The  
Institute has been designated as WHO Collaborating Center for District  
Health Systems based on Primary Health Care. The Ministry of Health and  
Family Welfare, Government of India has identified the institute as an  
Institute of Excellence for training and capacity building.

For more details please go through the Brochure  
\<[https://iihmr.edu.in/pages/download?file=app/webroot/files/training/brochure/92/operation-management-2017.pdf&gt](https://iihmr.edu.in/pages/download?file=app/webroot/files/training/brochure/92/operation-management-2017.pdf&gt);

& official web page  
\<[https://iihmr.edu.in/trainings&gt](https://iihmr.edu.in/trainings&gt);  
regarding the program.

Regards  
Rahul Sharma  
Program Coordinator  
IIHMR University, Jaipur, India  
rahul sharma \<rahulsharma1in@gmail.com\>
